High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing

Abstract excerpt

Hematopoietic stem/progenitor cell gene therapy (HSPC-GT) has shown clear neurological benefit in rare diseases, which is achieved through the engraftment of genetically modified microglia-like cells (MLCs) in the brain. Still, the engraftment dynamics and the nature of engineered MLCs, as well as their potential use in common neurogenerative diseases, have remained largely unexplored. Here, we comprehensively...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyotrophic Lateral Sclerosis Research
• Share to Neurogenesis and neuroplasticity mechanisms
• Share to Neuroinflammation and Neurodegeneration Mechanisms